Kaposi's sarcoma primary prevention
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Shyam Patel [2]; Associate Editor(s)-in-Chief: Farima Kahe M.D. [3]
Overview
Overview
There are no established measures for the primary prevention of Kaposi’s sarcoma. However, there are some measures to significantly lower the risk of disease such as avoiding high risk behavior and using antiviral drugs.
Primary Prevention
Primary Prevention
There are no established measures for the primary prevention of Kaposi’s sarcoma. However, there are some measures to significantly lower the risk of disease as followings:[1][2]
- Avoiding risky sexual practices, such as having unprotected sex
- Avoiding using intravenous (IV) needles that have been used by someone else
- Using antiviral drugs as prophylaxis
- Routine skin examinations (note that this is not supported well from a cost-effectiveness standpoint, but self-examination is encouraged)
References
References
- ↑ Casper C, Wald A (2007). “The use of antiviral drugs in the prevention and treatment of Kaposi sarcoma, multicentric Castleman disease and primary effusion lymphoma”. Curr. Top. Microbiol. Immunol. 312: 289–307. PMID 17089802.
- ↑ Goedert, J. J. (2002). “Risk Factors for Classical Kaposi’s Sarcoma”. CancerSpectrum Knowledge Environment. 94 (22): 1712–1718. doi:10.1093/jnci/94.22.1712. ISSN 1460-2105.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH